And so that gave us more confidence obviously here about what customers want, when they want it and we’ve got some pretty good visibility into that. Other businesses such as ultrasound that have more flow capabilities based on prospecting funnels and stuff, we have quite good visibility as well. So if we look at that backlog, we know what the cost €“ the input costs are going into that. We have €“ we know what the price is in the backlog. So again, for those deals, it’s quite good. We clearly have orders coming into the system that will feed into that backlog. We know what our current pricing is. And we’ve also either taken some price increases or had some that would cut in. And keep in mind, there’s a couple of different ways to think about price looking at your configurations and really optimizing them is something that we started last year.
And I think that’s of high value. Our new NPIs, we really focus on getting the right value for the customer and pricing it right the first time, which typically then aligns to making sure that we have the right gross margins associated with it. And then classic price increases on many of our products. So again, the combination of those gives us a pretty good view into how we see the year at this point, but probably more so a better lens on the first half.
Vijay Kumar: Understood. That’s helpful. And maybe one follow-up for Helmut. Look at EPS guidance here, 7% to 11% between your organic top line assumptions and margin expansion, I think operating profit should be growing close to double digits here. Any €“ what are you assuming for FX and any below the line sensitivity here on interest expense or other items that we need to be aware of?
Helmut Zodl: Yes. So Vijay, we have been obviously tightening up the range on the EPS guide. So the $3.60 to $3.75, we believe is right in the middle. When you look at the upper and lower end of the revenue and the margin expansion guide, so we wanted to tighten that range up. And to the assumption question, so there’s about 2.5 basis points of negative impact from FX assumed in those numbers, very little below the line. So that’s really how you should look at it.
Peter Arduini: Yes. And I would just say, Vijay, one of the things is we’ve got and we’ve talked about improving supply chain. But again, improving isn’t back to, say, the good old days. All of our input costs have some added cost to them. It’s why we put a lot of focus on variable cost productivity. We’re carrying some inventory from spot buys and things that was at higher rates. And we’re going to see much of that continue into 2023, but we have good visibility to it. And I think as we see how the economy plays out and how that plays out relative to inflation, we’ll have better insights about what we can do about it. But again, our first half visibility looks quite good at this point in time. And again, we’re optimistic that we’re going to continue to see improvements throughout the year.
Vijay Kumar: That’s helpful perspective. Thank you, guys.
Helmut Zodl: Thank you.
Operator: Thank you. Our next question comes from Larry Biegelsen with Wells Fargo. Your line is open.
Lawrence Biegelsen: Good morning,
Peter Arduini: Good morning, Larry.
Helmut Zodl: Good morning, Larry.
Lawrence Biegelsen: Hi, Pete. Hi, Helmet. Thanks for taking the question. One on the top line, one on the margins. Pete, you talked about clearly Q4 results were very strong, 18% in imaging. You talked about the backlog here. Is there any way to quantify this? Is there €“ I mean, is this somewhat of a catch-up, if you will, and what are your expectations for that for 2023? Clearly, you’re growing well in excess of historical market growth. And I had one follow-up.